On July 4，2026，the U.S. FDA issued a compliance notice for the import of amino acid raw materials for dietary supplements，bringing relevant products exported from China to the United States under stricter declaration and label management requirements。This change not only involves free amino acids such as cystine，tyrosine，and leucine，but also covers amino acid chelate raw materials，and is directly related to export declaration，customs clearance and release，label filing，and supply chain delivery，therefore it has a relatively strong practical impact on companies related to amino acid nutritional products，feed additives，and pharmaceutical intermediates。

What mandatory requirements are clarified in this notice

According to the information provided，the U.S. Food and Drug Administration（FDA）issued the 《Dietary Supplement Ingredient Import Compliance Notice #2026-07》 on July 4，2026。The notice makes clear that mandatory impurity profile declaration and bilingual label filing requirements will be implemented for free amino acids such as cystine，tyrosine，and leucine，as well as amino acid chelate raw materials。

Among them，the impurity profile declaration includes 12 indicators such as heavy metals，process residual hydrochloric acid/sulfuric acid，and biogenic amines。The new rules apply to all Chinese exporters。For goods that do not comply with the requirements，the notice states that they will face port detention and automatic refusal of entry。The information provided also shows that this guidance will directly affect the customs clearance efficiency and supply chain stability of importers of amino acid nutritional products，feed additives，and pharmaceutical intermediates。

The impact first falls on the coordination of customs declaration，procurement，and delivery

Higher requirements for data completeness at the export declaration end

From an industry perspective，direct exporters will be affected first，because this change turns impurity profile declaration and bilingual label filing from general compliance preparation into prerequisite requirements directly linked to entry results。The impact is mainly reflected in pre-shipment document preparation，the organization of supporting customs declaration documents，and information coordination with the importer。Companies need to focus on whether the testing materials，label content，and filing documents corresponding to the target products can form a consistent declaration chain。

Procurement and import processes place greater emphasis on suppliers’ documentation capabilities

For raw material procurement companies and importers，the impact is not only on price or supply itself，but on whether suppliers can stably provide impurity profile materials and supporting label filing content that meet the new requirements。If document preparation is insufficient，even if the goods themselves have already been produced，they may still encounter delays，detention，or refusal of entry during customs clearance。The resulting changes may be concentrated in procurement review，supplier screening，arrival schedule arrangements，and order delivery confirmation。

Processing and manufacturing companies need to simultaneously verify the compliance status of upstream raw materials

For processing and manufacturing companies that use relevant amino acid raw materials，whether the raw materials can enter smoothly will directly affect production scheduling and raw material substitution arrangements。From an analytical perspective，such companies need to pay more attention to the declaration consistency of upstream raw materials，especially whether there are coordination issues among impurity profile information，product uses，and label information。For businesses that rely on a relatively tight import schedule，supply chain stability will depend more than before on front-end compliance preparation。

Coordination pressure rises in testing and supply chain service processes

Testing service agencies，customs declaration partners，and supply chain service companies may also be affected，because the new rules move more compliance judgments forward to the document preparation stage before shipment and entry。From observation，this means that relevant service processes need to intervene earlier in data verification，declaration information organization，and label review。Although the information provided does not give specific implementation details，what can be determined is that the work around documents，testing，and customs clearance coordination will become more closely connected。

Which issues should businesses currently focus on more closely

First verify whether the products fall within the scope of these requirements

Companies currently need first to confirm whether the products they export or procure belong to the free amino acids or amino acid chelate raw materials indicated by the notice。Since the information provided specifically names categories such as cystine，tyrosine，and leucine，relevant companies should prioritize sorting out the shipment arrangements，orders in transit，and subsequent procurement plans for these products and similar categories。

Treat impurity profile declaration materials as a key pre-shipment review focus

From an analytical perspective，impurity profile declaration will become one of the core documents in this round of compliance changes。Companies need to focus on whether existing testing reports，technical documents，and declaration materials can cover the 12 indicators mentioned in the notice，especially whether items such as heavy metals，process residual hydrochloric acid/sulfuric acid，and biogenic amines can form clear correspondence at the documentation level。Since the input information does not provide more detailed implementation criteria，at this stage it is more appropriate to understand this as a key point that must be verified in advance，rather than remedied only at the customs clearance stage。

Bilingual label filing needs to remain consistent with trade documents

The bilingual label filing requirement means that labels are no longer only a matter at the packaging level，but may become a component that affects import compliance judgments。For exporters，importers，and brand owners，what deserves more attention is whether the label text，product descriptions，and declaration materials are consistent，so as to avoid information mismatches during filing，customs declaration，and port inspection。

Delivery cycles and supplier review methods may need adjustment

From observation，companies should re-examine delivery cycle buffers，supplier qualification reviews，and risk assessment methods for orders in transit in the short term。For U.S. import businesses that rely on Chinese suppliers，as well as procurement，logistics，and customs declaration teams that provide support for related businesses，it is now more necessary to incorporate the progress of compliance material preparation into order management，rather than judging delivery feasibility only according to traditional shipping schedules。

This is more like an implementation signal that has already taken effect

From industry observation，this information is more appropriately understood as an implementation signal that already has practical binding force，rather than merely a general policy discussion。The reason is that the information provided clearly states that the new rules apply to all Chinese exporters，and that non-compliant goods will face port detention and automatic refusal of entry。This means that market participants need to regard it as a rule change that directly affects customs clearance outcomes。

At the same time，however，it should also be noted that the currently known information still focuses on the notice itself and its core requirements，and the input does not provide more detailed implementation criteria，data formats，review standards，or feedback from actual implementation。From an analytical perspective，the industry still needs to continue paying attention to subsequent official statements，consistency in the import implementation process，and whether corresponding adjustments appear in procurement documents and business contracts。

Its significance for the industry lies in moving compliance forward

Overall，the core significance of this FDA update to the import requirements for amino acid raw materials for dietary supplements does not lie in adding a separate document，but in further moving impurity profile declaration and bilingual label filing forward as key conditions that affect entry results。For exporters，importers，procurement parties，and supply chain service processes，it is currently more appropriate to understand this information as a compliance constraint that has already taken effect，and on this basis re-check document preparation，supplier coordination，and delivery arrangements。As for the extent to which the subsequent impact will expand，continued observation in combination with implementation feedback is still required。

Basis of this article and key points for subsequent verification

This article is generated based on the information title，event occurrence time，and event summary provided by the user，with the content based on “The U.S. FDA updates the import compliance guidance for amino acid raw materials for dietary supplements，implementing new label and impurity profile declaration requirements from today”，the time “2026-07-04”，and the corresponding summary information。Such events usually also require further verification in combination with official announcements，regulatory agency releases，information from customs or trade authorities，industry association information，standards organization documents，and authoritative media reports。Since no specific official source links are provided in the input，the relevant original links and subsequent supporting explanations still need to be continuously verified。Content worth continued attention includes policy details，implementation criteria for certification or declaration，changes in procurement and bidding documents，industry feedback，and companies’ actual implementation status。